ATE459363T1 - Getrocknetes extrakt aus mit vaccinia-viren geimpfter, entzündeter kaninchenhaut und prozess zur herstellung - Google Patents

Getrocknetes extrakt aus mit vaccinia-viren geimpfter, entzündeter kaninchenhaut und prozess zur herstellung

Info

Publication number: ATE459363T1
Authority: AT; Austria
Prior art keywords: production; present; extract; rabbit skin; manufacture
Prior art date: 2004-12-01

Application number

AT05026077T

Other languages

English (en)

Inventor

Masaharu Kurohashi

Yoji Shibayama

Original Assignee

Nippon Zoki Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-01

Filing date

2005-11-30

Publication date

2010-03-15

2005-04-28 Priority claimed from JP2005132070A external-priority patent/JP3818657B2/ja

2005-10-13 Priority claimed from JP2005298472A external-priority patent/JP4024810B2/ja

2005-11-30 Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co

2010-03-15 Application granted granted Critical

2010-03-15 Publication of ATE459363T1 publication Critical patent/ATE459363T1/de

Links

238000004519 manufacturing process Methods 0.000 title abstract 8
241000283973 Oryctolagus cuniculus Species 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
206010046865 Vaccinia virus infection Diseases 0.000 title 1
241000700605 Viruses Species 0.000 title 1
208000007089 vaccinia Diseases 0.000 title 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
241000700618 Vaccinia virus Species 0.000 abstract 2
230000002757 inflammatory effect Effects 0.000 abstract 2
230000002401 inhibitory effect Effects 0.000 abstract 2
230000001689 kallikreinlike Effects 0.000 abstract 2
238000002360 preparation method Methods 0.000 abstract 2
239000007787 solid Substances 0.000 abstract 2
239000000126 substance Substances 0.000 abstract 2
229960005070 ascorbic acid Drugs 0.000 abstract 1
235000010323 ascorbic acid Nutrition 0.000 abstract 1
239000011668 ascorbic acid Substances 0.000 abstract 1
150000001720 carbohydrates Chemical class 0.000 abstract 1
238000001035 drying Methods 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
150000005846 sugar alcohols Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Developmental Biology & Embryology (AREA)
Zoology (AREA)
Virology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT05026077T 2004-12-01 2005-11-30 Getrocknetes extrakt aus mit vaccinia-viren geimpfter, entzündeter kaninchenhaut und prozess zur herstellung ATE459363T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2004348904		2004-12-01
JP2005132070A JP3818657B2 (ja)	2004-12-01	2005-04-28	乾燥物及びその製造方法
JP2005177334		2005-06-17
JP2005298472A JP4024810B2 (ja)	2005-06-17	2005-10-13	乾燥物及びその製造法

Publications (1)

Publication Number	Publication Date
ATE459363T1 true ATE459363T1 (de)	2010-03-15

Family

ID=36010950

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05026077T ATE459363T1 (de)	2004-12-01	2005-11-30	Getrocknetes extrakt aus mit vaccinia-viren geimpfter, entzündeter kaninchenhaut und prozess zur herstellung

Country Status (8)

Country	Link
US (3)	US20060134139A1 (de)
EP (1)	EP1669082B1 (de)
KR (1)	KR101307999B1 (de)
AT (1)	ATE459363T1 (de)
AU (1)	AU2005235903B2 (de)
CA (1)	CA2527750C (de)
DE (1)	DE602005019672D1 (de)
ES (1)	ES2341654T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4300370B2 (ja)	2007-03-13	2009-07-22	春三小林	上皮改善剤
CN101732348B (zh) *	2008-11-11	2015-01-14	威世药业（如皋）有限公司	牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
TWI483729B (zh)	2010-03-11	2015-05-11	Nippon Zoki Pharmaceutical Co	慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
KR101894754B1 (ko)	2010-10-14	2018-09-04	니폰 조키 세야쿠 가부시키가이샤	연골세포의 콜라겐 및 프로테오글리칸의 합성 촉진 방법
JP6469002B2 (ja)	2013-04-30	2019-02-13	日本臓器製薬株式会社	抽出物及び該抽出物を含有する製剤
US20170064616A1 (en) *	2015-08-28	2017-03-02	Qualcomm Incorporated	Small cell application platform
CN109512838B (zh) *	2017-09-15	2022-05-10	天津小西生物医药科技有限公司	一种兔皮提取物及其制备方法和用途
CN111065717B (zh)	2017-12-25	2024-02-20	日本精工株式会社	润滑剂组合物及封入有该润滑剂组合物的滚动轴承

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB697351A (en)	1951-01-16	1953-09-23	Masuichi Takino	Improved process for the manufacture of nerve sedatives
JPS5518694B2 (de) *	1973-04-02	1980-05-21
JPS5366412A (en) *	1976-10-30	1978-06-13	Sato Akihiko	Extracting and separating effective component of mushroom 1mannentake1
JPS53101515A (en)	1977-02-17	1978-09-05	Nippon Zoki Pharmaceutical Co	Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS5587724A (en)	1978-12-27	1980-07-02	Nippon Zoki Pharmaceut Co Ltd	Selective immune enhancer
JPS5777697A (en)	1980-11-04	1982-05-15	Nippon Zoki Pharmaceut Co Ltd	Physiologically active substance nsq
JPS57183720A (en)	1981-05-01	1982-11-12	Junji Mitani	Health drug for fish farming
JPS5835117A (ja)	1981-08-25	1983-03-01	Nippon Zoki Pharmaceut Co Ltd	新規生理活性物質ｎｓｈ
JPS58121217A (ja)	1982-01-13	1983-07-19	Takeo Kagitani	火傷薬
US4640361A (en) *	1985-12-13	1987-02-03	Halliburton Company	Thermally responsive aqueous silicate mixtures and use thereof
JPS62145022A (ja)	1985-12-18	1987-06-29	Sofuto Shirika Kk	食中毒症用薬剤
JPS63185398A (ja) *	1986-09-10	1988-07-30	Nippon Zoki Pharmaceut Co Ltd	生理活性物質測定法
FR2610523B1 (fr)	1987-02-06	1991-04-26	Synthelabo	Extrait dose de silicium biogene, sa preparation et son application en therapeutique
FR2617488B1 (fr)	1987-07-01	1990-03-09	Tab	Procede de fabrication de structures organisees de collagene, notamment d'origine humaine, et structures organisees de collagene correspondantes
JP2651674B2 (ja)	1987-07-23	1997-09-10	日本臓器製薬株式会社	新規生理活性物質及びその製造方法
JPS6479657A (en) *	1987-09-22	1989-03-24	Nippon Zoki Pharmaceutical Co	Vital decision of medicine
US4863518A (en) *	1987-10-19	1989-09-05	Blount David H	Production of polyol-alkali metal silicate glass emulsion
US4985254A (en)	1987-11-06	1991-01-15	Nippon Zoki Pharmaceutical Co., Ltd.	Method of treating ischemic diseases
DE3801178A1 (de)	1988-01-18	1989-07-27	Hoechst Ag	Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
JPH0825885B2 (ja)	1988-04-15	1996-03-13	日本臓器製薬株式会社	特発性血小板減少性紫斑病治療剤
ATE94401T1 (de)	1988-04-30	1993-10-15	Nippon Zoki Pharmaceutical Co	Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.
JP2539665B2 (ja) *	1988-06-20	1996-10-02	日本臓器製薬株式会社	神経疾患治療剤
JP2539669B2 (ja)	1988-07-15	1996-10-02	日本臓器製薬株式会社	糖尿病性神経障害治療剤
JPH0273020A (ja)	1988-09-09	1990-03-13	Arusu Japan:Kk	経皮鎮痛消炎症剤
TW209174B (de) *	1991-04-19	1993-07-11	Takeda Pharm Industry Co Ltd
JPH06122630A (ja)	1992-10-12	1994-05-06	Taiyo Yakuhin Kogyo Kk	安定な塩酸セフォチアム製剤
JP2588109B2 (ja) *	1993-03-19	1997-03-05	日本臓器製薬株式会社	鎮痛剤
CN1042093C (zh)	1993-06-09	1999-02-17	罗正都	竹汁饮料
JPH0733666A (ja)	1993-07-27	1995-02-03	Kyowa Hakko Kogyo Co Ltd	インドロカルバゾール誘導体の安定化法
JP2594222B2 (ja)	1993-09-28	1997-03-26	日本臓器製薬株式会社	新規生理活性物質−ｋｆ
CN1046516C (zh) *	1994-04-25	1999-11-17	协和发酵工业株式会社	化合物dx－52－1的稳定方法和其冻干组合物
FR2720068A1 (fr)	1994-05-20	1995-11-24	Inst Nat Sante Rech Med	Protéines d'interaction avec la protéine Nef du virus HIV1, séquences d'acides nucléiques codant pour ces protéines et leur utilisation pour le criblage d'agents anti-viraux anti-HIV.
JP2594222Y2 (ja)	1994-11-30	1999-04-26	シャープ株式会社	ジャーポット
FR2732022B1 (fr)	1995-03-22	1997-05-23	Exsymol Sa	Extraction de composes organiques de silicium biologiquement actifs d'origine algale
JP3852786B2 (ja)	1995-04-25	2006-12-06	日本臓器製薬株式会社	骨萎縮改善剤
US6290967B1 (en) *	1996-12-20	2001-09-18	Merck & Co., Inc.	Stabilizers for lyophilized vaccines
US6051238A (en) *	1996-12-20	2000-04-18	Merck & Co., Inc.	Stabilizers for lyophilized mumps vaccines
JP4033936B2 (ja) *	1997-01-08	2008-01-16	日本臓器製薬株式会社	一酸化窒素産生抑制剤
JPH1180005A (ja) *	1997-09-12	1999-03-23	Nippon Zoki Pharmaceut Co Ltd	骨粗鬆症治療剤
JPH11139977A (ja)	1997-11-07	1999-05-25	Nippon Zoki Pharmaceut Co Ltd	Ｎｅｆ作用抑制剤
KR19990044835A (ko)	1997-11-28	1999-06-25	고니시 진우에몬	생약추출물
JP2000016942A (ja)	1998-04-27	2000-01-18	Nippon Zoki Pharmaceut Co Ltd	虚血性疾患治療剤
AU2402399A (en) *	1998-04-27	2000-11-02	Nippon Zoki Pharmaceutical Co., Ltd.	A therapeutic agent for ischemic diseases
US6306345B1 (en) *	1998-05-06	2001-10-23	Universal Preservation Technologies, Inc.	Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
JP2000086528A (ja) *	1998-09-16	2000-03-28	Shokubutsu Kakusan Kaihatsu Kk	玉ねぎ顆粒又は錠剤の製造方法及び玉ねぎ顆粒又は錠剤
JP2000336034A (ja)	1999-03-19	2000-12-05	Nippon Zoki Pharmaceut Co Ltd	ケモカイン産生促進剤
CN1272365A (zh) *	1999-04-15	2000-11-08	日本脏器制药株式会社	新型生理活性物质
TWI233805B (en) *	1999-07-01	2005-06-11	Fujisawa Pharmaceutical Co	Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CN1312080A (zh) *	2000-02-18	2001-09-12	日本脏器制药株式会社	含有脂肪酸的组合物
US6913900B2 (en) *	2001-08-29	2005-07-05	Nippon Zoki Pharmaceutical Co., Ltd.	Plasma prekallikrein activation and kallikrein production assay
JP2003095955A (ja)	2001-09-25	2003-04-03	Takada Seiyaku Kk	ヒアルロン酸ナトリウムの安定化固形組成物
TWI342778B (en)	2002-10-31	2011-06-01	Nippon Zoki Pharmaceutical Co	Therapeutic agent for fibromyalgia
CN1207005C (zh)	2002-10-31	2005-06-22	威世药业（如皋）有限公司	含生物活性物质的兔皮和其用途
JP2004300146A (ja)	2003-03-17	2004-10-28	Nippon Zoki Pharmaceut Co Ltd	感染防御剤
US7060308B2 (en) *	2003-06-04	2006-06-13	Ramaswamy Rajendran	Caralluma extract products and processes for making the same
US20060134646A1 (en) *	2004-12-17	2006-06-22	Ansari Aftab A	Method for treatment of HIV infection

2005
- 2005-11-21 KR KR1020050111145A patent/KR101307999B1/ko not_active Expired - Fee Related
- 2005-11-23 CA CA2527750A patent/CA2527750C/en not_active Expired - Lifetime
- 2005-11-23 AU AU2005235903A patent/AU2005235903B2/en not_active Ceased
- 2005-11-25 US US11/286,644 patent/US20060134139A1/en not_active Abandoned
- 2005-11-30 ES ES05026077T patent/ES2341654T3/es not_active Expired - Lifetime
- 2005-11-30 DE DE602005019672T patent/DE602005019672D1/de not_active Expired - Lifetime
- 2005-11-30 EP EP05026077A patent/EP1669082B1/de not_active Expired - Lifetime
- 2005-11-30 AT AT05026077T patent/ATE459363T1/de not_active IP Right Cessation
2012
- 2012-02-02 US US13/365,048 patent/US8568789B2/en not_active Expired - Fee Related
2013
- 2013-09-19 US US14/031,085 patent/US20140017311A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20120135083A1 (en)	2012-05-31
DE602005019672D1 (de)	2010-04-15
US20140017311A1 (en)	2014-01-16
ES2341654T3 (es)	2010-06-24
EP1669082A1 (de)	2006-06-14
EP1669082B1 (de)	2010-03-03
CA2527750A1 (en)	2006-06-01
CA2527750C (en)	2014-09-16
AU2005235903B2 (en)	2011-08-25
KR101307999B1 (ko)	2013-09-12
KR20060061228A (ko)	2006-06-07
US8568789B2 (en)	2013-10-29
AU2005235903A1 (en)	2006-06-15
US20060134139A1 (en)	2006-06-22

Legal Events

Date	Code	Title	Description
2010-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
Amit et al.	2013	Phytosome: Phytolipid drug delivery system for improving bioavailability of herbal drug
JP2021147335A (ja)	2021-09-27	ニトロ化タンパク質分解剤
NO20073719L (no)	2007-08-22	Kjemiske forbindelser
ME00556A (en)	2011-12-20	Freeze-dried pantoprazole preparation and pantoprazole injection
JP7599219B2 (ja)	2024-12-13	液体プロポリス抽出物、その製剤およびその使用
ES2717652T3 (es)	2019-06-24	Potenciador de expresión del gen de la filagrina
WO2011056775A3 (en)	2011-11-03	Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
Kang et al.	2016	Antioxidant and neuroprotective effects of Doenjang prepared with Rhizopus, Pichia, and Bacillus
DE602004016403D1 (de)	2008-10-23	Topische pharmazeutische Zusammensetzungen enthaltend aktive natürliche Bestandteile zur Verhütung und Behandlung von mucosalen Entzündungprozessen
ATE459363T1 (de)	2010-03-15	Getrocknetes extrakt aus mit vaccinia-viren geimpfter, entzündeter kaninchenhaut und prozess zur herstellung
Gopal et al.	2013	Investigation of in-vitro anti-oxidant, anti-inflammatory and anti-arthritic activity of aerial parts of Securinega leucopyrus (Willd.) Muell
NO20090067L (no)	2009-03-17	Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer
KR102371272B1 (ko)	2022-03-07	들기름 추출물 및 향부자 추출물을 포함하는 피부 트러블 개선용 조성물
JP2007023015A5 (de)	2007-03-29
CN100581534C (zh)	2010-01-20	高良姜提取物的制备方法
ITMI20012142A1 (it)	2003-04-17	Composizioni farmaceutiche per uso topico contenenti estratti di erbemedicinali ad attivita' antilogistica e cicatrizzante
JP5858726B2 (ja)	2016-02-10	インボルクリン発現抑制剤
JP2008174526A (ja)	2008-07-31	アレルゲン不活化剤、及びそれを含有する皮膚外用剤、又はアレルゲン不活化用製品
JP5096750B2 (ja)	2012-12-12	アレルゲン不活化剤、及びそれを含有する皮膚外用剤、又はアレルゲン不活化用製品
KR20140123658A (ko)	2014-10-23	홍화싹 추출물을 유효성분으로 하는 항산화 및 항염증 기능성 조성물
Bruschi et al.	2017	Nanostructured propolis as therapeutic systems with antimicrobial activity
KR101547996B1 (ko)	2015-08-27	상처 치료, 상처 회복 또는 흉터 생성 억제용 피부 외용제 조성물
KR20180056065A (ko)	2018-05-28	막실라리아 추출물의 제조 방법, 상기 방법에 의해 제조된 막실라리아 추출물, 및 상기 막실라리아 추출물을 포함하는 화장료 조성물 및 약학 조성물
Nwaehujor Chinaka et al.	2013	Anticoagulant and antioxidant activities of Dracaena arborea Leaves (Wild.) Link
Kumar et al.	2020	Antioxidant, Antinociceptive and Anti-inflammatory activities of Rhynchosia minima (L) DC